Most interestingly, the aforementioned prognostic impact of PD-L1 was interacting with CRP potentially suggesting that – besides the suppression of the adaptive immune system – a systemic acute phase response worsens outcome in MPE patients with PD-L1 positive tumours. Here, CRP is linked to neoplasm.